Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization is a research paper published in Leukemia (2025). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH HHS
Grant: S10 OD026717
NCI NIH HHS
Grant: R50 CA211404
NCI NIH HHS
Grant: R01 CA275007
NCI NIH HHS
Grant: T32 CA236764
NCI NIH HHS
Grant: L30 CA284414
NCI NIH HHS
Grant: R01 CA271455
NIDDK NIH HHS
Grant: U54 DK126108
NHLBI NIH HHS
Grant: R35 HL166430
National Institutes of Health
Grant: 1U54DK126108-01A1
Cincinnati Cooperative Center of Excellence in Hematology
National Institutes of Health
Grant: 1R01CA271455-01
Dissecting innate immune signaling in pre-leukemia evolution
National Institutes of Health
Grant: 1R35HL166430-01
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
National Institutes of Health
Grant: 5T32CA236764-05
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
National Institutes of Health
Grant: 5R50CA211404-04
Therapeutic insights through patient derived leukemia xenografts
National Institutes of Health
Grant: 5R01CA275007-02
Therapeutic targeting of IRAK4 in MDS
MeSH Terms
Keywords